Pancreatic Adenocarcinoma, Version 2.2014

Margaret A. Tempero, Mokenge P. Malafa, Stephen W. Behrman, Al B Benson III, Ephraim S. Casper, E. Gabriela Chiorean, Vincent Chung, Steven J. Cohen, Brian Czito, Anitra Engebretson, Mary Feng, William G. Hawkins, Joseph Herman, John P. Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Andrew M. Lowy, Wen Wee Ma, Nipun B. Merchant & 13 others Sean J. Mulvihill, Peter Muscarella, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Sushanth Reddy, Aaron R. Sasson, Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Deborah A. Freedman-Cass

Research output: Contribution to journalReview article

207 Citations (Scopus)

Abstract

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.

Original languageEnglish (US)
Pages (from-to)1083-1093
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number8
DOIs
StatePublished - Aug 1 2014

Fingerprint

Adenocarcinoma
Guidelines
Exocrine Pancreas
Neoadjuvant Therapy
Drug Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Tempero, M. A., Malafa, M. P., Behrman, S. W., Benson III, A. B., Casper, E. S., Chiorean, E. G., ... Freedman-Cass, D. A. (2014). Pancreatic Adenocarcinoma, Version 2.2014. JNCCN Journal of the National Comprehensive Cancer Network, 12(8), 1083-1093. https://doi.org/10.6004/jnccn.2014.0106
Tempero, Margaret A. ; Malafa, Mokenge P. ; Behrman, Stephen W. ; Benson III, Al B ; Casper, Ephraim S. ; Chiorean, E. Gabriela ; Chung, Vincent ; Cohen, Steven J. ; Czito, Brian ; Engebretson, Anitra ; Feng, Mary ; Hawkins, William G. ; Herman, Joseph ; Hoffman, John P. ; Ko, Andrew ; Komanduri, Srinadh ; Koong, Albert ; Lowy, Andrew M. ; Ma, Wen Wee ; Merchant, Nipun B. ; Mulvihill, Sean J. ; Muscarella, Peter ; Nakakura, Eric K. ; Obando, Jorge ; Pitman, Martha B. ; Reddy, Sushanth ; Sasson, Aaron R. ; Thayer, Sarah P. ; Weekes, Colin D. ; Wolff, Robert A. ; Wolpin, Brian M. ; Burns, Jennifer L. ; Freedman-Cass, Deborah A. / Pancreatic Adenocarcinoma, Version 2.2014. In: JNCCN Journal of the National Comprehensive Cancer Network. 2014 ; Vol. 12, No. 8. pp. 1083-1093.
@article{62452d43b3e24100a31f19d29465f245,
title = "Pancreatic Adenocarcinoma, Version 2.2014",
abstract = "The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.",
author = "Tempero, {Margaret A.} and Malafa, {Mokenge P.} and Behrman, {Stephen W.} and {Benson III}, {Al B} and Casper, {Ephraim S.} and Chiorean, {E. Gabriela} and Vincent Chung and Cohen, {Steven J.} and Brian Czito and Anitra Engebretson and Mary Feng and Hawkins, {William G.} and Joseph Herman and Hoffman, {John P.} and Andrew Ko and Srinadh Komanduri and Albert Koong and Lowy, {Andrew M.} and Ma, {Wen Wee} and Merchant, {Nipun B.} and Mulvihill, {Sean J.} and Peter Muscarella and Nakakura, {Eric K.} and Jorge Obando and Pitman, {Martha B.} and Sushanth Reddy and Sasson, {Aaron R.} and Thayer, {Sarah P.} and Weekes, {Colin D.} and Wolff, {Robert A.} and Wolpin, {Brian M.} and Burns, {Jennifer L.} and Freedman-Cass, {Deborah A.}",
year = "2014",
month = "8",
day = "1",
doi = "10.6004/jnccn.2014.0106",
language = "English (US)",
volume = "12",
pages = "1083--1093",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "8",

}

Tempero, MA, Malafa, MP, Behrman, SW, Benson III, AB, Casper, ES, Chiorean, EG, Chung, V, Cohen, SJ, Czito, B, Engebretson, A, Feng, M, Hawkins, WG, Herman, J, Hoffman, JP, Ko, A, Komanduri, S, Koong, A, Lowy, AM, Ma, WW, Merchant, NB, Mulvihill, SJ, Muscarella, P, Nakakura, EK, Obando, J, Pitman, MB, Reddy, S, Sasson, AR, Thayer, SP, Weekes, CD, Wolff, RA, Wolpin, BM, Burns, JL & Freedman-Cass, DA 2014, 'Pancreatic Adenocarcinoma, Version 2.2014', JNCCN Journal of the National Comprehensive Cancer Network, vol. 12, no. 8, pp. 1083-1093. https://doi.org/10.6004/jnccn.2014.0106

Pancreatic Adenocarcinoma, Version 2.2014. / Tempero, Margaret A.; Malafa, Mokenge P.; Behrman, Stephen W.; Benson III, Al B; Casper, Ephraim S.; Chiorean, E. Gabriela; Chung, Vincent; Cohen, Steven J.; Czito, Brian; Engebretson, Anitra; Feng, Mary; Hawkins, William G.; Herman, Joseph; Hoffman, John P.; Ko, Andrew; Komanduri, Srinadh; Koong, Albert; Lowy, Andrew M.; Ma, Wen Wee; Merchant, Nipun B.; Mulvihill, Sean J.; Muscarella, Peter; Nakakura, Eric K.; Obando, Jorge; Pitman, Martha B.; Reddy, Sushanth; Sasson, Aaron R.; Thayer, Sarah P.; Weekes, Colin D.; Wolff, Robert A.; Wolpin, Brian M.; Burns, Jennifer L.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 12, No. 8, 01.08.2014, p. 1083-1093.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pancreatic Adenocarcinoma, Version 2.2014

AU - Tempero, Margaret A.

AU - Malafa, Mokenge P.

AU - Behrman, Stephen W.

AU - Benson III, Al B

AU - Casper, Ephraim S.

AU - Chiorean, E. Gabriela

AU - Chung, Vincent

AU - Cohen, Steven J.

AU - Czito, Brian

AU - Engebretson, Anitra

AU - Feng, Mary

AU - Hawkins, William G.

AU - Herman, Joseph

AU - Hoffman, John P.

AU - Ko, Andrew

AU - Komanduri, Srinadh

AU - Koong, Albert

AU - Lowy, Andrew M.

AU - Ma, Wen Wee

AU - Merchant, Nipun B.

AU - Mulvihill, Sean J.

AU - Muscarella, Peter

AU - Nakakura, Eric K.

AU - Obando, Jorge

AU - Pitman, Martha B.

AU - Reddy, Sushanth

AU - Sasson, Aaron R.

AU - Thayer, Sarah P.

AU - Weekes, Colin D.

AU - Wolff, Robert A.

AU - Wolpin, Brian M.

AU - Burns, Jennifer L.

AU - Freedman-Cass, Deborah A.

PY - 2014/8/1

Y1 - 2014/8/1

N2 - The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.

AB - The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.

UR - http://www.scopus.com/inward/record.url?scp=84906258991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906258991&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0106

DO - 10.6004/jnccn.2014.0106

M3 - Review article

VL - 12

SP - 1083

EP - 1093

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 8

ER -